Skip to main content

Table 1 Effect of TXA

From: The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial

Events

RR

95% CI

Myocardial infarction

0.96

0.48-1.90

Stroke

1.25

0.47-3.31

Deep venous thrombosis

0.77

0.37-1.61

Renal failure

0.73

0.16-3.32